SetPoint Medical picks up $30 mln Series D
Santa Clarita, California-based SetPoint Medical, a developer of bioelectronic therapy for chronic inflammatory diseases, has raised $30 million in Series D funding. The investors included New Enterprise Associates, Morgenthaler, Medtronic, Boston Scientific, Topspin and Action Potential Venture Capital.
28 August 2017•2 mins read
